Intravenous Therapy

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 71802 Experts worldwide ranked by ideXlab platform

Jiang Ping - One of the best experts on this subject based on the ideXlab platform.

  • The practice and effect of quality control of Intravenous Therapy in our hospital
    Journal of Nursing Administration, 2005
    Co-Authors: Jiang Ping
    Abstract:

    Objective To sponsor the professional management of hospital Intravenous Therapy and to improve the quality of Intravenous Therapy constantly.Methods The idea of professional management of hospital Intravenous Therapy was sponsored and the following measures were carried out,such as establishing quality control organization of hospital Intravenous Therapy,building the basement of professional training,trying out the system of qualification and certification of specialty nurses of Intravenous Therapy,and bringing new products and technology of Intravenous Therapy into hospital nursing management system.Result This practice promoted the specialty development,quality control and training management of hospital Intravenous Therapy.(Conclusion The) quality control of hospital Intravenous Therapy could effectively improve the management level of Intravenous Therapy and the quality of nursing staff.

R. G. Finch - One of the best experts on this subject based on the ideXlab platform.

  • Patient education and communication in non-inpatient Intravenous Therapy--a review.
    European Journal of Haematology, 2009
    Co-Authors: J. M. Davies, Adrian C. Newland, R. G. Finch
    Abstract:

    :  This paper reviews patient education and communication elements of non-inpatient Intravenous Therapy schemes in the United States and the United Kingdom. Common characteristics of these services include: definition of the components of the scheme at all levels; patient selection; patient education; and good communications. A metaplan carried out among UK healthcare professionals highlighted education and communication issues as important factors for ensuring successful Therapy. Communication issues are difficult to define or modify. Specific experience from the United States and the United Kingdom is presented and the common elements in these programmes are emphasized. Results of the assessment of patient education are presented. This collective experience may prove useful for other centres setting up similar Therapy schemes.

Elizabeth Lafuente-cabrero - One of the best experts on this subject based on the ideXlab platform.

  • Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety
    Drugs in R&D, 2020
    Co-Authors: Silvia Manrique-rodríguez, Irene Heras-hidalgo, M. Sagrario Pernia-lópez, Ana Herranz-alonso, M. Camino Río Pisabarro, M. Belén Suárez-mier, M. Antonia Cubero-pérez, Verónica Viera-rodríguez, Noemí Cortés-rey, Elizabeth Lafuente-cabrero
    Abstract:

    Background Intravenous drug administration is associated with potential complications, such as phlebitis. The physiochemical characteristics of the infusate play a very important role in some of these problems. Aim The aim of this study was to standardize the dilutions of Intravenous drugs most commonly used in hospitalized adult patients and to characterize their pH, osmolarity and cytotoxic nature to better guide the selection of the most appropriate vascular access. Methods The project was conducted in three phases: (i) standardization of Intravenous Therapy, which was conducted using a modified double-round Delphi method; (ii) characterization of the dilutions agreed on in the previous phase by means of determining the osmolarity and pH of each of the agreed concentrations, and recording the vesicant nature based on the information in literature; and (iii) algorithm proposal for selecting the most appropriate vascular access, taking into account the information gathered in the previous phases. Results In total, 112 drugs were standardized and 307 different admixtures were assessed for pH, osmolarity and vesicant nature. Of these, 123 admixtures (40%), had osmolarity values >600 mOsm/L, pH < 4 or > 9, or were classified as vesicants. In these cases, selection of the most suitable route of infusion and vascular access device is crucial to minimize the risk of phlebitis-type complications. Conclusions Increasing safety of Intravenous Therapy should be a priority in the healthcare settings. Knowing the characteristics of drugs to assess the risk involved in their administration related to their physicochemical nature may be useful to guide decision making regarding the most appropriate vascular access and devices.

J. M. Davies - One of the best experts on this subject based on the ideXlab platform.

  • Patient education and communication in non-inpatient Intravenous Therapy--a review.
    European Journal of Haematology, 2009
    Co-Authors: J. M. Davies, Adrian C. Newland, R. G. Finch
    Abstract:

    :  This paper reviews patient education and communication elements of non-inpatient Intravenous Therapy schemes in the United States and the United Kingdom. Common characteristics of these services include: definition of the components of the scheme at all levels; patient selection; patient education; and good communications. A metaplan carried out among UK healthcare professionals highlighted education and communication issues as important factors for ensuring successful Therapy. Communication issues are difficult to define or modify. Specific experience from the United States and the United Kingdom is presented and the common elements in these programmes are emphasized. Results of the assessment of patient education are presented. This collective experience may prove useful for other centres setting up similar Therapy schemes.

Ron Keren - One of the best experts on this subject based on the ideXlab platform.

  • Prolonged Intravenous Therapy Versus Early Transition to Oral Antimicrobial Therapy for Acute Osteomyelitis in Children
    Pediatrics, 2009
    Co-Authors: Theoklis E. Zaoutis, A. R. Localio, Kateri H. Leckerman, Stephanie Saddlemire, D. Bertoch, Ron Keren
    Abstract:

    OBJECTIVES. Early transition from Intravenous to oral antimicrobial Therapy for acute osteomyelitis in children has been suggested as a safe and effective alternative to traditional prolonged Intravenous Therapy via central venous catheter, but no studies have directly compared these 2 treatment modalities. We sought to compare the effectiveness of early transition from Intravenous to oral antimicrobial Therapy versus prolonged Intravenous antimicrobial Therapy for the treatment of children with acute osteomyelitis. METHODS. We conducted a retrospective cohort study of children aged 2 months to 17 years diagnosed with acute osteomyelitis between 2000 and 2005 at 29 freestanding children9s hospitals in the United States to confirm the extent of variation in the use of early transition to oral Therapy. We used propensity scores to adjust for potential differences between children treated with prolonged Intravenous Therapy and logistic regression to model the association of outcome (treatment failure rates within 6 months of diagnosis) and difference in the mode of Therapy within hospitals and across hospitals. RESULTS. Of the 1969 children who met inclusion criteria, 1021 received prolonged Intravenous Therapy and 948 received oral Therapy. The use of prolonged Intravenous Therapy varied significantly across hospitals (10%–95%). The treatment failure rate was 5% (54 of 1021) in the prolonged Intravenous Therapy group and 4% (38 of 948) in the oral Therapy group. There was no significant association between treatment failure and the mode of antimicrobial Therapy. Thirty-five (3.4%) children in the prolonged Intravenous Therapy group were readmitted for a catheter-associated complication. CONCLUSIONS. Treatment of acute osteomyelitis with early transition to oral Therapy is not associated with a higher risk of treatment failures and avoids the risks of prolonged Intravenous Therapy through central venous catheters.